• 425 Citations
  • 8 h-Index
20082020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Syed Mujtaba Rizvi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 425 Citations
  • 8 h-Index
  • 11 Article
  • 3 Review article
  • 2 Letter
  • 1 Chapter

ENGINE: A Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1

Nowakowski, G. S., Zhu, J., Zhang, Q., Brody, J., Sun, X., Maly, J., Song, Y., Rizvi, S., Song, Y., Lansigan, F., Jing, H., Cao, J., Lue, J. K., Luo, W., Zhang, L., Li, L., Han, I., Sun, J., Jivani, M., Liu, Y. & 2 others, Heineman, T. & Smith, S. D., May 2020, In : Future Oncology. 16, 15, p. 991-999 9 p.

Research output: Contribution to journalArticle

Open Access
  • 1 Scopus citations

    Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients

    Jia, B., Wang, L., Claxton, D. F., Ehmann, W. C., Rybka, W. B., Mineishi, S., Rizvi, S., Shike, H., Bayerl, M., Schell, T. D., Hohl, R. J. & Zheng, H., Mar 1 2018, In : Blood Cancer Journal. 8, 3, 34.

    Research output: Contribution to journalLetter

    12 Scopus citations
  • 5 Scopus citations

    A new era of immunotherapy in prostate cancer

    Pizzola, C., Rizvi, S. M. & Joshi, M., Aug 1 2016, In : Current Molecular Pharmacology. 9, 3, p. 217-225 9 p.

    Research output: Contribution to journalReview article

  • 2 Scopus citations